Literature DB >> 26306715

Endorsing good quality assurance practices in molecular pathology: risks and recommendations for diagnostic laboratories and external quality assessment providers.

Lien Tembuyser1, Elisabeth M C Dequeker2.   

Abstract

Quality assurance is an indispensable element in a molecular diagnostic laboratory. The ultimate goal is to warrant patient safety. Several risks that can compromise high quality procedures are at stake, from sample collection to the test performed by the laboratory, the reporting of test results to clinicians, and the organization of effective external quality assessment schemes. Quality assurance should therefore be safeguarded at each level and should imply a holistic multidisciplinary approach. This review aims to provide an overview of good quality assurance practices and discusses certain risks and recommendations to promote and improve quality assurance for both diagnostic laboratories and for external quality assessment providers. The number of molecular targets is continuously rising, and new technologies are evolving. As this poses challenges for clinical implementation and increases the demand for external quality assessment, the formation of an international association for improving quality assurance in molecular pathology is called for.

Entities:  

Keywords:  Biological markers; Diagnostic testing; External quality assessment; Individualized medicine; Molecular pathology; Quality assurance

Mesh:

Substances:

Year:  2015        PMID: 26306715     DOI: 10.1007/s00428-015-1839-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  55 in total

Review 1.  Molecular testing in oncology: problems, pitfalls and progress.

Authors:  Cathal P O'Brien; Sarah E Taylor; John J O'Leary; Stephen P Finn
Journal:  Lung Cancer       Date:  2014-01-03       Impact factor: 5.705

2.  Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer.

Authors:  Luisa Foltran; Giovanna De Maglio; Nicoletta Pella; Paola Ermacora; Giuseppe Aprile; Elena Masiero; Mariella Giovannoni; Emiliana Iaiza; Giovanni Gerardo Cardellino; Stefania Eufemia Lutrino; Micol Mazzer; Manuela Giangreco; Federica Edith Pisa; Stefano Pizzolitto; Gianpiero Fasola
Journal:  Future Oncol       Date:  2015       Impact factor: 3.404

3.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

4.  Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Authors:  Pilar Garrido; Javier de Castro; Ángel Concha; Enriqueta Felip; Dolores Isla; Fernando López-Ríos; Luis Paz-Ares; José Ramírez; Julián Sanz; José Javier Gómez
Journal:  Clin Transl Oncol       Date:  2012-05       Impact factor: 3.405

5.  Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors:  Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956

6.  External quality assessment of BRAF molecular analysis in melanoma.

Authors:  Zandra C Deans; Andrew Wallace; Brendan O'Sullivan; Andrew Purvis; Suzanne Camus; Jennifer A Fairley; David Gonzalez
Journal:  J Clin Pathol       Date:  2013-10-04       Impact factor: 3.411

Review 7.  Clinical integration of next-generation sequencing technology.

Authors:  R R Gullapalli; M Lyons-Weiler; P Petrosko; R Dhir; M J Becich; W A LaFramboise
Journal:  Clin Lab Med       Date:  2012-12       Impact factor: 1.935

Review 8.  Prognostic and predictive biomarkers in lung cancer. A review.

Authors:  Erik Thunnissen; Kimberly van der Oord; Michael den Bakker
Journal:  Virchows Arch       Date:  2014-01-14       Impact factor: 4.064

Review 9.  Technical and implementation issues in using next-generation sequencing of cancers in clinical practice.

Authors:  D Ulahannan; M B Kovac; P J Mulholland; J-B Cazier; I Tomlinson
Journal:  Br J Cancer       Date:  2013-07-25       Impact factor: 7.640

10.  Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication.

Authors:  Paul Lochhead; Aya Kuchiba; Yu Imamura; Xiaoyun Liao; Mai Yamauchi; Reiko Nishihara; Zhi Rong Qian; Teppei Morikawa; Jeanne Shen; Jeffrey A Meyerhardt; Charles S Fuchs; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2013-07-22       Impact factor: 13.506

View more
  7 in total

Review 1.  Pathologists and liquid biopsies: to be or not to be?

Authors:  Paul Hofman; Helmut H Popper
Journal:  Virchows Arch       Date:  2016-08-23       Impact factor: 4.064

Review 2.  [Interlaboratory comparisons-a central means of external quality assurance].

Authors:  Korinna Jöhrens; Maja Grassow; Gustavo Baretton; Florian Sperling
Journal:  Pathologie (Heidelb)       Date:  2022-08-10

3.  Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect.

Authors:  Cleo Keppens; Elke Boone; Paula Gameiro; Véronique Tack; Elisabeth Moreau; Elizabeth Hodges; Paul Evans; Monika Brüggemann; Ian Carter; Dido Lenze; Maria Eugenia Sarasquete; Markus Möbs; Hongxiang Liu; Elisabeth M C Dequeker; Patricia J T A Groenen
Journal:  Virchows Arch       Date:  2021-03-08       Impact factor: 4.064

Review 4.  Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

Authors:  Véronique Hofman; Sandra Lassalle; Coraline Bence; Elodie Long-Mira; Sacha Nahon-Estève; Simon Heeke; Virginie Lespinet-Fabre; Catherine Butori; Marius Ilié; Paul Hofman
Journal:  Cancers (Basel)       Date:  2018-03-13       Impact factor: 6.639

Review 5.  Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL.

Authors:  K Dufraing; F Fenizia; E Torlakovic; N Wolstenholme; Z C Deans; E Rouleau; M Vyberg; S Parry; E Schuuring; Elisabeth M C Dequeker
Journal:  Virchows Arch       Date:  2020-10-13       Impact factor: 4.064

Review 6.  The Significance of External Quality Assessment Schemes for Molecular Testing in Clinical Laboratories.

Authors:  Nele Laudus; Lynn Nijs; Inne Nauwelaers; Elisabeth M C Dequeker
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575

7.  A stitch in time saves nine: external quality assessment rounds demonstrate improved quality of biomarker analysis in lung cancer.

Authors:  Cleo Keppens; Véronique Tack; Nils 't Hart; Lien Tembuyser; Ales Ryska; Patrick Pauwels; Karen Zwaenepoel; Ed Schuuring; Florian Cabillic; Luigi Tornillo; Arne Warth; Wilko Weichert; Elisabeth Dequeker
Journal:  Oncotarget       Date:  2018-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.